Phase II Study of PS-341 in Low Grade Lymphoproliferative Disorders
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Bortezomib (Primary)
- Indications Follicular lymphoma; Lymphoproliferative disorders; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2008 Status changed from recruiting to in progress, as reported in ClinicalTrials.gov.
- 06 Sep 2005 New trial record.